With a world-class team of urologists, oncologists, and physician-scientists, the Department of Urology at Northwestern Medicine has been at the forefront of clinical and research advancements in urology for more than a century. Northwestern Medicine Urology is committed to providing personalized, integrative, and innovative urologic care and conducting leading-edge research for the prevention, diagnosis and treatment of urologic conditions. In light of this commitment, the Urology Program at Northwestern Memorial Hospital is the highest-ranked program in Illinois and No.11 in the country by U.S. News & World Report, 2021 – 2022 and among the top three NIH-funded urology departments in the nation.
AI tool predicts survival in patients undergoing RP in the PLCO trial
November 29th 2023"Specifically when we stratified by tertiles, we saw that at 15 years there was a significant difference in cancer-specific survival for those who had a high MMAI score vs lower MMAI scores," says Eric Li, MD.
Dr. Murphy on the influence of genomic testing in prostate cancer
November 7th 2023"For those people in the intervention arm who did get the assay, the doctors were more likely to prefer active treatment with surgery or radiation compared to the control group," says Adam B. Murphy, MD, MBA, MSCI.
Northwestern University to host genitourinary robotics reconstruction course
September 13th 2023“The purpose of the course is really to bring together like-minded surgeons and physicians who are interested in robotic reconstructive surgery to really come together to not only build a network, but also discuss complex situations, discuss tips and tricks, and also to review the most salient literature in this space,” says Ziho Lee, MD.
Expert: Availability of multiple PSMA agents “a boon” for patients
July 6th 2023“I think the prostate cancer community has benefited a lot in the past several years with the advent of enhanced imaging tools to help us better stage patients with prostate cancer both at their initial diagnosis and if, unfortunately, they have a recurrence,” says Edward M. Schaeffer, MD, PhD.
Dr. Conor Driscoll on the effect of TNF alpha inhibitor use on prostate cancer risk
July 4th 2023"I would say that the take-home message of the study is that these immunosuppressive medications have alterations in the microbiology in a lot of these organs and a lot of these tumors," says Conor Driscoll, MD.
Long-term TNF alpha inhibitor use linked with decreased risk of prostate cancer
June 30th 2023"Prostate cancer showed a decreased risk, which we thought was very interesting, because it was the only cancer for which that signal existed, that there is possibly a protective effect of these medications," says Conor Driscoll, MD.
Dr. Catalona on the slow adoption of active surveillance in the United States
June 8th 2023"It pretty much has been adopted around the world so that about 80% of men who are diagnosed with low-risk prostate cancer go on active surveillance. In Sweden, it's about 80%. That's considered the goal. But the United States has been slow in adopting this," says William J. Catalona, MD.
Dr. Siddiqui and Dr. Li on the power of nomograms in prostate cancer detection
May 9th 2023“I think, overall, nomograms are a really powerful tools just because there are so many different clinical variables that we consider when we talk to patients about whether to proceed with prostate biopsy,” says Eric Li, MD.